Literature DB >> 31917913

Clinical Practice Guidelines for Functional Dyspepsia in Korea.

Jung Hwan Oh1, Joong Goo Kwon2, Hye-Kyung Jung3, Chung Hyun Tae3, Kyung Ho Song4, Seung Joo Kang5, Sung Eun Kim6, Kyoungwon Jung6, Joon Sung Kim1, Jong Kyu Park7, Ki Bae Bang8, Myong Ki Baeg9, Jeong Eun Shin8, Cheol Min Shin10, Ju Yup Lee11, Hyun Chul Lim12.   

Abstract

Functional dyspepsia (FD) is a chronic upper gastrointestinal (GI) symptom complex that routine diagnostic work-up, such as endoscopy, blood laboratory analysis, or radiological examination, fails to identify a cause. It is highly prevalent in the World population, and its response to the various available therapeutic strategies is only modest because of the heterogenous nature of its pathogenesis. Therefore, FD represents a heavy medical burden for healthcare systems. We constituted a guideline development committee to review the existing guidelines on the management of functional dyspepsia. This committee drafted statements and conducted a systematic review and meta-analysis of various studies, guidelines, and randomized control trials. External review was also conducted by selected experts. These clinical practice guidelines for FD were developed based on evidence recently accumulated with the revised version of FD guidelines released in 2011 by the Korean Society of Neurogastroenterology and Motility. These guidelines apply to adults with chronic symptoms of FD and include the diagnostic role of endoscopy, Helicobacter pylori screening, and systematic review and meta-analyses of the various treatment options for FD (proton pump inhibitors, H. pylori eradication, and tricyclic antidepressants), especially according to the FD subtype. The purpose of these new guidelines is to aid the understanding, diagnosis, and treatment of FD, and the targets of the guidelines are clinicians, healthcare workers at the forefront of patient care, patients, and medical students. The guidelines will continue to be revised and updated periodically.

Entities:  

Keywords:  Dyspepsia; Endoscopy; Evidence-based medicine; Guideline; Proton pump inhibitors

Year:  2020        PMID: 31917913     DOI: 10.5056/jnm19209

Source DB:  PubMed          Journal:  J Neurogastroenterol Motil        ISSN: 2093-0879            Impact factor:   4.924


  6 in total

1.  Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies.

Authors:  Lorenzo Drago; Gabriele Meroni; Dario Pistone; Luigi Pasquale; Giuseppe Milazzo; Fabio Monica; Salvatore Aragona; Leonardo Ficano; Roberto Vassallo
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

2.  Efficacy and Safety of DWJ1252 Compared With Gasmotin Treatment: Once Met 3 Times Tablets.

Authors:  Jae Hak Kim
Journal:  J Neurogastroenterol Motil       Date:  2021-01-30       Impact factor: 4.924

3.  Development and Validity Assessment of a Self-evaluation Questionnaire for Functional Dyspepsia: A Multicenter Prospective Study in Korea.

Authors:  Kyoungwon Jung; Hye-Kyung Jung; Joong Goo Kwon; Chung Hyun Tae; Ki Bae Bang; Jong Kyu Park; Ju Yup Lee; Cheol Min Shin; Jung Hwan Oh; Kyung Ho Song; Oh Young Lee; Myung-Gyu Choi
Journal:  J Neurogastroenterol Motil       Date:  2022-01-30       Impact factor: 4.924

Review 4.  Chinese herbal medicine for functional dyspepsia: a network meta-analysis of prokinetic-controlled randomised trials.

Authors:  Leonard Ho; Claire C W Zhong; Charlene H L Wong; Justin C Y Wu; Karina K H Chan; Irene X Y Wu; Ting Hung Leung; Vincent C H Chung
Journal:  Chin Med       Date:  2021-12-20       Impact factor: 5.455

5.  The Role of Medial Prefrontal Cortex in Acupuncture Treatment for Functional Dyspepsia.

Authors:  Yuke Teng; Tao Yin; Yue Yang; Ruirui Sun; Zilei Tian; Peihong Ma; Zhaoxuan He; Yuzhu Qu; Liuyang Huang; Yuan Chen; Fang Zeng
Journal:  Front Neurosci       Date:  2022-04-07       Impact factor: 5.152

6.  Comparing diagnostic performance of Cantonese-Chinese version of Rome IV criteria and a short Reference Standard for functional dyspepsia in China.

Authors:  Leonard Ho; Shuijiao Chen; Fai Fai Ho; Charlene H L Wong; Jessica Y L Ching; Pui Kuan Cheong; Irene X Y Wu; Xiaowei Liu; Ting Hung Leung; Justin C Y Wu; Vincent C H Chung
Journal:  BMC Gastroenterol       Date:  2022-10-12       Impact factor: 2.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.